for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-GW Pharmaceuticals Qtrly Loss Per ADS 312.0 Cents

May 8 (Reuters) - GW Pharmaceuticals PLC:

* GW PHARMACEUTICALS PLC REPORTS FISCAL SECOND QUARTER 2018 FINANCIAL RESULTS AND OPERATIONAL PROGRESS

* GW PHARMACEUTICALS - EPIDIOLEX (CANNABIDIOL) NDA PDUFA GOAL DATE SCHEDULED FOR JUNE 27, 2018

* GW PHARMACEUTICALS PLC - QTRLY LOSS PER SHARE 26.0 CENTS

* GW PHARMACEUTICALS PLC - QTRLY LOSS PER ADS 312.0 CENTS Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up